Share

Search your stocks

Ctrl+K

ZENITHDRUGZenith Drugs Ltd.

63.3(-2.24%)

1W: -2.78%

1M: -8.55%

1Y: +1.73%

Zenith Drugs Quarterly Results

Pros & Cons

POSITIVES

Strong revenue growth of 12% in the latest quarter indicates robust demand for products.
Operating margin improved by 3%, showcasing better cost management and operational efficiency.
Net profit margin reached a record high of 15%, reflecting enhanced profitability.

NEGATIVES

Raw material costs surged by 10%, impacting overall profitability despite revenue growth.
Debt levels increased by 5%, raising concerns over financial leverage and future cash flow.
Sales growth slowed to 5% in comparison to the previous quarter, suggesting potential market saturation.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-